Dr. Yee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Masonic Cancer Center, University of Minnesota
420 Delaware Street SE
Minneapolis, MN 55455Phone+1 612-626-8487- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
- University of North Carolina HospitalsResidency, Internal Medicine, 1981 - 1985
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981
Certifications & Licensure
- MN State Medical License 1999 - 2024
- TX State Medical License 1989 - 2007
- NC State Medical License 1984 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer Start of enrollment: 2006 Jul 01
- CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
- Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.Haiyun Wang, Douglas Yee, David Potter, Patricia Jewett, Christina Yau, Heather Beckwith, Allison Watson, Nicholas O'Grady, Amy Wilson, Susie Brain, Paula Pohlmann, , ...> ;Breast Cancer Research and Treatment. 2024 Apr 1
- Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
- Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.Michael A Carpenter, Nuri A Temiz, Mahmoud A Ibrahim, Matthew C Jarvis, Margaret R Brown, Prokopios P Argyris, William L Brown, Gabriel J Starrett, Douglas Yee, Reuben...> ;Plos Genetics. 2023 Nov 1
- Join now to see all
Lectures
- The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast CancerAmerican Society of Clinical Oncology(ASCO), Chicago, Illinois - 8/9/2013
- The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast CancerAmerican Society of Clinical Oncology(ASCO), Los Angeles, California - 8/16/2013
Press Mentions
- University of Minnesota Team Announced as Finalists for Worldwide Cancer Grand ChallengesJuly 13th, 2021
- UMN Researchers Discuss New Ethical Dilemmas During the PandemicMarch 19th, 2021
- Insulin Receptor Substrate-1 (IRS-1) Mediates Progesterone Receptor-Driven Stemness and Endocrine Resistance in Oestrogen Receptor+ Breast CancerNovember 4th, 2020
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: